US FDA declines to approve Regenxbio's rare disease drug

Regenxbio

09/02/2026 21:11

Feb 9 (Reuters) - Regenxbio RGNX.O said on Monday the U.S. Food and Drug Administration has declined to approve its drug for a rare disease.

 (Reporting by Sneha S K; Editing by Alan Barona)

 ((Sneha.SK@thomsonreuters.com;))